Re­call re­port: Pfiz­er pulls even more Chan­tix lots as ni­trosamine con­t­a­m­i­na­tion wor­ries grow

4 years ago
Manufacturing

Roche's Foun­da­tion Med­i­cine is get­ting a new 16-sto­ry home in Boston's Sea­port Dis­trict

4 years ago
Pharma

Fore­site re­cruits Prin­cip­ia vet Mar­tin Babler — and his old team — to oc­cu­py the C-suite of a start­up

4 years ago
People
Startups

Ox­ford Bio­med­ica sees new in­vest­ment for man­u­fac­tur­ing; Twist gets a part­ner to help build out dis­cov­ery li­braries 

4 years ago
News Briefing

Covid-19 roundup: BAR­DA pumps $60M more in­to SAB treat­ment; EMA to de­cide on boost­ers next month

4 years ago
Coronavirus

Covid-19 man­u­fac­tur­ing roundup: Bharat Biotech turns to oth­er pro­duc­ers to up sup­ply; Brazil, Ar­genti­na land mR­NA ...

4 years ago
Coronavirus
Manufacturing

Look­ing to make donor cells ob­so­lete, an ex-Har­vard re­searcher gets off-the-shelf stem cell biotech off the ground

4 years ago
Financing

Mitch Mc­Connell, top Re­pub­li­cans ques­tion Biden on get­ting ahead of FDA on Covid-19 boost­ers

4 years ago
FDA+
Coronavirus

As­traZeneca teams up with Im­pe­r­i­al off­shoot Vax­E­quity on an RNA 3.0 ef­fort

4 years ago
Deals
R&D

In­cyte's rux­oli­tinib scores its sec­ond ap­proval in two days, this time in chron­ic graft-ver­sus-host dis­ease

4 years ago
FDA+

Eli Lil­ly gets be­hind the lat­est ap­proach to solv­ing gene ther­a­py's de­liv­ery prob­lem

4 years ago
Financing
Startups

FDA au­tho­rizes Pfiz­er's vac­cine boost­er for se­niors, those at high risk for se­vere Covid-19

4 years ago
Coronavirus

Fi­nal analy­sis of US-fund­ed Mod­er­na Covid vac­cine tri­al shows 98% ef­fi­ca­cy against se­vere dis­ease

4 years ago
Coronavirus

The fire un­der Glax­o­SmithK­line's Em­ma Walm­s­ley grows as an­oth­er well-known ac­tivist in­vestor grabs its pitch­fork — ...

4 years ago
People
Pharma

Hexa­gon Bio rais­es $61M to con­tin­ue ef­forts to turn fun­gi in­to drugs

4 years ago
Financing

Blue­bird sends blood dis­or­der drug to FDA for ap­proval; CG On­col­o­gy en­ters col­lab­o­ra­tion with Roche for Tecen­triq

4 years ago
News Briefing

Covid-19 roundup: Pfiz­er tees up 500M vac­cine dos­es for do­na­tion in ex­pand­ed US pact; Ear­ly remde­sivir helps stave ...

4 years ago
Coronavirus

The FDA ob­jects to biotech bil­lion­aire Bob Dug­gan’s PhI­II plans — and he’s not budg­ing

4 years ago
FDA+

FDA+ roundup: Bs­U­FA III ready for show­time, court tells FDA to re-work com­pound­ing plan, new guid­ance up­dates and ...

4 years ago
FDA+

In­side look: How a po­ten­tial part­ner­ship turned in­to a $1.9B buy­out for Sanofi

4 years ago
Deals

With world still in sore need of dos­es, Clover says its Covid-19 vac­cine is 67% ef­fec­tive in Phase III

4 years ago
R&D
Coronavirus

Lux­tur­na in­ven­tor Jean Ben­nett starts a new gene ther­a­py com­pa­ny to tack­le rare dis­eases left be­hind by phar­ma, VCs

4 years ago
Startups

In­cyte nabs ap­proval of top­i­cal rux­oli­tinib in atopic der­mati­tis, but gets slapped with JAK warn­ing

4 years ago
FDA+

The End­points 11: They've got mad mon­ey and huge am­bi­tions. It's time to go big or go home

4 years ago
Startups
Special
First page Previous page 636637638639640641642 Next page Last page
A service from the Financial Times